UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2016-09, Vol.96 (1), p.21-29

2016

Volltextzugriff (PDF)

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience

Oral oncology, 2018-05, Vol.80, p.16-22

2018

Volltextzugriff (PDF)

The landscape of digital resources in radiation oncology

Technical innovations & patient support in radiation oncology, 2022-12, Vol.24, p.19-24

2022

Volltextzugriff (PDF)

The role of chemotherapy in the management of olfactory neuroblastoma: A 40‐year surveillance, epidemiology, and end results registry study

Health science reports, 2021-06, Vol.4 (2), p.e257-n/a

2021

Volltextzugriff (PDF)

The ruse of reduction – comment to Zeng et al

Journal of neuro-oncology, 2023-11, Vol.165 (2), p.385-386

2023

Volltextzugriff (PDF)

Who Knows When it is Right Under Your Nose? A Case of Cutaneous Squamous Cell Carcinoma with Involvement of the Nasal Vestibule

International journal of radiation oncology, biology, physics, 2023-03, Vol.115 (4), p.817-818

2023

Volltextzugriff (PDF)

Nationwide changes in radiation oncology travel and location of care before and during the COVID-19 pandemic

Radiation oncology journal , 2023, 41(2), , pp.108-119

2023

Volltextzugriff (PDF)

Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

Cancer, 2021-12, Vol.127 (24), p.4565-4573

2021

Volltextzugriff (PDF)

The time course of semantic and relational processing during verbal analogical reasoning

Brain and cognition, 2019-02, Vol.129, p.25-34

2019

Volltextzugriff (PDF)

Long-term outcomes following proton therapy for non-metastatic central nervous system germinoma in children and adolescents

Radiotherapy and oncology, 2024-09, Vol.198, p.110371, Article 110371

2024

Volltextzugriff (PDF)

A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Cancer, 2020-05, Vol.126 (10), p.2146-2152

2020

Volltextzugriff (PDF)

Dose and Volume De-Escalation for Human Papillomavirus–Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes

International journal of radiation oncology, biology, physics, 2020-07, Vol.107 (4), p.662-671

2020

Volltextzugriff (PDF)

A pilot study of the pan‐class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer

Head & neck, 2019-11, Vol.41 (11), p.3842-3849

2019

Volltextzugriff (PDF)

A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study

Cancer, 2020-07, Vol.126 (14), p.3237-3243

2020

Volltextzugriff (PDF)

Mapping Mastery: Evaluation of a Radiation Oncology Competency-Based Curriculum's Alignment with Current ACGME Milestones

International journal of radiation oncology, biology, physics, 2024-07, Vol.119 (4), p.e3-e3

2024

Volltextzugriff (PDF)

Exploring the Feasibility and Utility of Entrustable Professional Activities in Resident Assessment and Feedback: A Pilot Survey Study

International journal of radiation oncology, biology, physics, 2024-07, Vol.119 (4), p.e3-e3

2024

Volltextzugriff (PDF)

Nationwide changes in radiation oncology travel and location of care before and during the COVID-19 pandemic

Radiation oncology journal, 2023-06, Vol.41 (2), p.108-119

2023

Volltextzugriff (PDF)

De-escalation in HPV-negative locally advanced head and neck squamous cell cancer (LA-HNSCC) in patients after induction chemotherapy: A retrospective case series

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18090-e18090

2018

Volltextzugriff (PDF)

Rare Bilateral Variation of the Extensor Carpi Radialis Longus Muscle

The FASEB journal, 2017-04, Vol.31 (S1)

2017

Volltextzugriff (PDF)

A randomized phase II network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Cancer, 2020-02, Vol.126 (10), p.2146-2152

2020

Volltextzugriff (PDF)

A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent/metastatic head and neck cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6039-6039

2017

Volltextzugriff (PDF)

Association of immune-related adverse events (irAEs) with improved response, progression-free survival, and overall survival for patients with metastatic head and neck cancer receiving anti-PD-1 therapy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6014-6014

2018

Volltextzugriff (PDF)

Association of a baseline neutrophil-to-lymphocyte ratio (NLR) with progression-free and overall survival in head and neck cancer patients receiving anti-PD-1 therapy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6038-6038

2018

Volltextzugriff (PDF)

Association of low serum albumin concentration with reduced overall survival for patients with metastatic head and neck cancer receiving anti-programmed death receptor-1 therapy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6057-6057

2018

Volltextzugriff (PDF)

High-accuracy HPV testing versus p16 IHC using multiple clinically relevant outcomes: The University of Chicago Experience

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6020-6020

2018

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(43)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Oncology
(12)
Humans
(10)
Male
(7)
Adult
(6)
Female
(6)
Aged
(5)
Aged, 80 And Over
(5)
Immunotherapy
(5)
Metastasis
(5)
Middle Aged
(5)
Radiology, Nuclear Medicine & Medical Imaging
(5)
Animals
(4)
Head & Neck Cancer
(4)
Metastases
(4)
Squamous Cell Carcinoma
(4)
Analysis
(3)
Antineoplastic Combined Chemotherapy Protocols - Administration & Dosage
(3)
Aphids - Genetics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience

The landscape of digital resources in radiation oncology

The role of chemotherapy in the management of olfactory neuroblastoma: A 40‐year surveillance, epidemiology, and end results registry study

The ruse of reduction – comment to Zeng et al

Who Knows When it is Right Under Your Nose? A Case of Cutaneous Squamous Cell Carcinoma with Involvement of the Nasal Vestibule

Nationwide changes in radiation oncology travel and location of care before and during the COVID-19 pandemic

Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

The time course of semantic and relational processing during verbal analogical reasoning

Long-term outcomes following proton therapy for non-metastatic central nervous system germinoma in children and adolescents

A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Dose and Volume De-Escalation for Human Papillomavirus–Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes

A pilot study of the pan‐class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer

A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study

Mapping Mastery: Evaluation of a Radiation Oncology Competency-Based Curriculum's Alignment with Current ACGME Milestones

Exploring the Feasibility and Utility of Entrustable Professional Activities in Resident Assessment and Feedback: A Pilot Survey Study

Nationwide changes in radiation oncology travel and location of care before and during the COVID-19 pandemic

De-escalation in HPV-negative locally advanced head and neck squamous cell cancer (LA-HNSCC) in patients after induction chemotherapy: A retrospective case series

Rare Bilateral Variation of the Extensor Carpi Radialis Longus Muscle

A randomized phase II network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent/metastatic head and neck cancer

Association of immune-related adverse events (irAEs) with improved response, progression-free survival, and overall survival for patients with metastatic head and neck cancer receiving anti-PD-1 therapy

Association of a baseline neutrophil-to-lymphocyte ratio (NLR) with progression-free and overall survival in head and neck cancer patients receiving anti-PD-1 therapy

Association of low serum albumin concentration with reduced overall survival for patients with metastatic head and neck cancer receiving anti-programmed death receptor-1 therapy

High-accuracy HPV testing versus p16 IHC using multiple clinically relevant outcomes: The University of Chicago Experience

Suchergebnisse filtern